TVM Capital Healthcare Announces US$ 17 Million Investment into neurocare
DUBAI, UAE, April 24, 2024 /PRNewswire/ -- TVM Capital Healthcare, a specialist healthcare private equity firm headquartered in Dubai and Singapore, today announced a US$ 17 million investment into Munich-headquartered neurocare group AG (neurocare), a leading innovator in personalized mental health care, providing solutions to empower clinicians to deliver best care to their patients. TVM Capital Healthcare's investment will enable neurocare to execute on its international growth plans, including expansion in the US and market entry into the Kingdom of Saudi Arabia, as well as support the development of new hardware and software innovations. It is the ninth investment of TVM Capital Healthcare to improve local access to quality healthcare in the MENA region.
- DUBAI, UAE, April 24, 2024 /PRNewswire/ -- TVM Capital Healthcare, a specialist healthcare private equity firm headquartered in Dubai and Singapore, today announced a US$ 17 million investment into Munich-headquartered neurocare group AG (neurocare), a leading innovator in personalized mental health care, providing solutions to empower clinicians to deliver best care to their patients.
- It is the ninth investment of TVM Capital Healthcare to improve local access to quality healthcare in the MENA region.
- Tristan de Boysson, Managing Partner, TVM Capital Healthcare, stated: "This investment is part of our strategy of investing in highly innovative, best-in-class healthcare solutions that improve access to quality care across the globe.
- Thomas Mechtersheimer, Founder and CEO of neurocare group, added: "We are very pleased to announce the cooperation with TVM Capital Healthcare, a strong partner with deep industry experience.